NCT00301730View on ClinicalTrials.gov

Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

October 31, 2005

Conditions
Breast CancerMetastatic Cancer
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

therapeutic tumor infiltrating lymphocytes

BIOLOGICAL

trastuzumab

DRUG

paclitaxel

PROCEDURE

conventional surgery

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00301730 - Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung | Biotech Hunter | Biotech Hunter